Houston, Texas — According to state and local economic development sources Healgen Scientific plans to invest $1,013,000.00 to build out 21,065 square feet of new space in Houston. The company plans to occupy the new space at 3818 Fuqua Street in Houston, on or about January 1, 2022. According to the company website Healgen Scientific, a wholly owned subsidiary of Zhejiang Orient Gene Biotech Co., Ltd, develops, manufactures and commercializes in-vitro diagnostic test systems worldwide. Our product portfolio spans multiple testing categories and analytes to meet various clinical and laboratory needs. Our testing platforms include rapid testing, molecular diagnostics, and multiplex flow cytometry. Since our inception in 2007, we have strived to develop devices that meet and exceed industry standards. The manufacturing process is supported by our interactive and highly-skilled Research and Development team, who are actively redefining the efficiency and design of our products. Our ambition is worldwide, and we currently provide products to customers in: USA, Europe, Middle-East, South Asia, Africa and Latin America for a total of 80+ countries. Our mission is to provide premier support to our distributors and partners. We have a flexible strategy on business cooperation, where we offer OEM options. Our success is supported by our professional personnel and good manufacturing practice.

To learn more about Healgen Scientific, visit http://www.healgen.com/

Company Contact:
Cindy Horton, Chief Executive Officer
https://www.linkedin.com/in/cindy-horton-37684a212/
713-733-8088

SOURCE: http://www.intelligence360.io
Copyright (c) 2021 SI360 Inc. All rights reserved